Acute lymphoblastic leukemia secondary to myeloproliferative neoplasms or after lenalidomide exposure.

Alhuraiji, Ahmad; Naqvi, Kiran; Huh, Yang O; Ho, Coty; Verstovsek, Srdan; Bose, Prithviraj.

Afiliação

Alhuraiji A; Department of Leukemia University of Texas MD Anderson Cancer Center Houston 77030 Texas.
Naqvi K; Department of Leukemia University of Texas MD Anderson Cancer Center Houston 77030 Texas.
Huh YO; Department of Hematopathology University of Texas MD Anderson Cancer Center Houston 77030 Texas.
Ho C; Oklahoma Cancer Specialists and Research Institute Tulsa 74133 Oklahoma.
Verstovsek S; Department of Leukemia University of Texas MD Anderson Cancer Center Houston 77030 Texas.
Bose P; Department of Leukemia University of Texas MD Anderson Cancer Center Houston 77030 Texas.

Clin Case Rep ; 6(1): 155-161, 2018 01.

Article em En | MEDLINE | ID: mdl-29375856